Clinical Management and Prevention of Adverse Pregnancy Outcomes
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Reproductive and Developmental Biology".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 97
Special Issue Editors
Interests: molecular, ultrasound and clinical characterization of pregnancy complications; placental histology
Special Issues, Collections and Topics in MDPI journals
Interests: perinatal ultrasound; serum markers for complications of pregnancy; histopathology of the placenta; neonatal pathological conditions
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The clinical characteristics of various pregnancy complications are pivotal to prevent maternal and neonatal morbidity and mortality. Molecular, sonographic and clinical screening are essential to optimize the management of complicated pregnancies. Pre-eclampsia and gestational diabetes are among the most common complications and are unique to humans. Chronic diseases also represent risk for fetoplacental development. Therapeutic strategies completed with novel screening methods help augment early screening during gestation. Significant advances can be provided in the prediction and prevention of preterm birth if multiple risk factors can be identified. Increasing evidence points to the substantial role of genetic, immunologic and other fetoplacental development-related factor levels in screening for pregnancy outcomes. Cytogenetic and molecular mapping are identified as a useful tool in almost every complication of pregnancies, and even in stillbirth. Gestational diseases (such as gestational diabetes mellitus or intrahepatic cholestasis) are a growing public health problem worldwide, and nutrigenetic and epigenetic characterization may decrease the short- and long-term complications for both mother and offspring. Pregnancy affected by any complication might have a transgenerational effect. Inventing additional screening specifics may help us to better understand the clinical course of pregnancies and chronic pathologies, and avoid adverse outcomes.
Dr. Zoltan Kozinszky
Dr. Andrea Suranyi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pathologic pregnancies
- ultrasound
- clinical and molecular characteristics
- fetal pathologies
